Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 1.32 M1.2 M1.03 M1.42 M 4.96 M Research & development ———— — Operating income -1.31 M-1.2 M-826 K-1.54 M -4.87 M Non-Operating Income, Total ———— — Interest expense, net of interest capitalized ———— — Non-Operating Income, excl. Interest Expenses ———— — Unusual income/expense ———— — Pretax income -1.14 M-1.04 M-694 K-1.42 M -4.3 M Equity in earnings ———— — Taxes 0000 0 Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations -1.14 M-1.04 M-694 K-1.42 M -4.3 M Discontinued operations ———— — Net income -1.14 M-1.04 M-694 K-1.42 M -4.3 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders -1.14 M-1.04 M-694 K-1.42 M -4.3 M Basic earnings per share (Basic EPS) -0.05-0.05-0.03-0.07 -0.2 Diluted earnings per share (Diluted EPS) -0.05-0.05-0.03-0.07 -0.2 Average basic shares outstanding 21.04 M21.04 M21.04 M21.04 M — Diluted shares outstanding 21.04 M21.04 M21.04 M21.04 M — EBITDA -1.12 M-1.02 M-673 K-1.4 M -4.22 M EBIT -1.14 M-1.04 M-694 K-1.42 M -4.3 M Cost of revenue 1.66 M1.22 M1.69 M1.65 M 6.22 M Other cost of goods sold ———— — Depreciation & amortization (cash flow) 20 K21 K21 K20 K 82 K